SEARCH

SEARCH BY CITATION

References

  • 1
    Fields LE, Burt VL, Cutler JA, et al. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension. 2004;44:398404.
  • 2
    Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA. 2003;290:199206.
  • 3
    Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults, 1999–2004. Hypertension. 2007;49:6975.
  • 4
    American Heart Association. Heart Disease and Stroke Statistics—2006 Update. Dallas, TX: American Heart Association; 2006.
  • 5
    The Seventh Report of the Joint National Committee on Prevention. Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:12061252.
  • 6
    Wolf-Maier K, Cooper RS, Kramer H, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004;43:1017.
  • 7
    Franklin SS. Hypertension in older people: part 1. J Clin Hypertens (Greenwich). 2006;8:444449.
  • 8
    Ferdinand KC. Managing cardiovascular risk in minority patients. J Natl Med Assoc. 2005;97:459466.
  • 9
    Hertz RP, Unger AN, Cornell JA, et al. Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med. 2005;165:20982104.
  • 10
    Ferdinand KC, Saunders E. Hypertension-related morbidity and mortality in African Americans: why we need to do better. J Clin Hypertens (Greenwich). 2006;8(suppl 1):2130.
  • 11
    Levine RS, Foster JE, Fullilove RE, et al. Black-white inequalities in mortality and life expectancy, 1933–1999: implications for Healthy People 2010. Public Health Rep. 2001;116:474483.
  • 12
    Guidelines Committee. 2003 European Society of Hypertension—European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:10111053.
  • 13
    Cifkova R, Erdine S, Fagard R, et al. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens. 2003;21:17791786.
  • 14
    Weber MA. Creating a combination antihypertensive regimen: what does the research show? J Clin Hypertens (Greenwich). 2003;5(suppl 3):1220.
  • 15
    Sica DA. Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats. Drugs. 2002;62:443462.
  • 16
    Elliott WJ. Optimizing medication adherence in older persons with hypertension. Int Urol Nephrol. 2003;35:557562.
  • 17
    Philipp T, Smith TR, Glazer R, et al. Two randomized, double blind, multicenter, multifactorial, placebo-controlled, parallel-group studies to evaluate the efficacy and safety of valsartan and amlodipine combined and alone in hypertensive patients [published online ahead of print April 2, 2007]. Clin Ther. doi:10.1016/j.clinthera.2007.03.018.
  • 18
    Douglas JG, Bakris GL, Epstein M, et al., for the Hypertension in African Americans Working Group. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med. 2003;163:525541.
  • 19
    Arauz-Pacheco C, Parrott MA, Raskin P, for the American Diabetes Association. Hypertension management in adults with diabetes. Diabetes Care. 2004;27(suppl 1):S65S67.
  • 20
    Curb JD, Borhani NO, Blaszkowski TP, et al. Long-term surveillance for adverse effects of antihypertensive drugs. JAMA. 1985;253:32633268.
  • 21
    Payne KA, Esmonde-White S. Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence? Curr Hypertens Rep. 2000;2:515524.
  • 22
    The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:29812997.
  • 23
    Osterberg L, Blaschke T. Drug therapy: adherence to medication. N Engl J Med. 2005;353:487497.